niacinamide has been researched along with tacrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikiciuk-Olasik, E; Szymański, P; Zurek, E | 1 |
| Bajda, M; Lázniček, M; Lázničková, A; Malawska, B; Markowicz, M; Mikiciuk-Olasik, E; Szymański, P | 1 |
| Chen, JG; Huang, JG; Jiang, FC; Liang, X; Liu, JM; Long, LH; Luo, H; Rao, J; Shen, ZC; Wang, F; Wu, PF; Xie, QG; Zhou, J | 1 |
3 other study(ies) available for niacinamide and tacrine
| Article | Year |
|---|---|
New tacrine-hydrazinonicotinamide hybrids as acetylcholinesterase inhibitors of potential interest for the early diagnostics of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrazines; Indicators and Reagents; Kinetics; Niacinamide; Radiopharmaceuticals; Tacrine; Technetium Compounds | 2006 |
2,3-dihydro-1H-cyclopenta[b]quinoline derivatives as acetylcholinesterase inhibitors-synthesis, radiolabeling and biodistribution.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isotope Labeling; Models, Molecular; Molecular Structure; Niacinamide; Quinolines; Structure-Activity Relationship; Tacrine; Tissue Distribution | 2012 |
ST09, a Novel Thioester Derivative of Tacrine, Alleviates Cognitive Deficits and Enhances Glucose Metabolism in Vascular Dementia Rats.
Topics: Acetylcholinesterase; Animals; Apoptosis; Cell Line, Transformed; Cerebral Cortex; Cognition Disorders; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Fluorodeoxyglucose F18; Glucose; Hippocampus; In Vitro Techniques; Male; Maze Learning; Niacinamide; Nootropic Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Tacrine | 2016 |